Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use - Yahoo Finance

Retrieved on: 2024-01-15 16:16:13

Tags for this article:

Cancer immunotherapy

Antineoplastic drugs

Pharmaceutical industry

Programmed cell death protein 1

Regeneron Pharmaceuticals

Cervical cancer

Novo Nordisk

Click the tags to see associated articles and topics

Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use - Yahoo Finance. View article details on HISWAI: https://finance.yahoo.com/news/merck-mrk-keytruda-okd-fda-143000322.html

Excerpt

In partnership with Moderna, Merck is developing a personalized mRNA therapeutic cancer vaccine (V940/mRNA-4157) in combination with Keytruda for the ...

Article found on: finance.yahoo.com

View Original Article